125 related articles for article (PubMed ID: 17379289)
1. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.
Bree A; Schlerman FJ; Wadanoli M; Tchistiakova L; Marquette K; Tan XY; Jacobson BA; Widom A; Cook TA; Wood N; Vunnum S; Krykbaev R; Xu X; Donaldson DD; Goldman SJ; Sypek J; Kasaian MT
J Allergy Clin Immunol; 2007 May; 119(5):1251-7. PubMed ID: 17379289
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys.
Kasaian MT; Tan XY; Jin M; Fitz L; Marquette K; Wood N; Cook TA; Lee J; Widom A; Agostinelli R; Bree A; Schlerman FJ; Olland S; Wadanoli M; Sypek J; Gill D; Goldman SJ; Tchistiakova L
J Pharmacol Exp Ther; 2008 Jun; 325(3):882-92. PubMed ID: 18337474
[TBL] [Abstract][Full Text] [Related]
3. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
Kasaian MT; Donaldson DD; Tchistiakova L; Marquette K; Tan XY; Ahmed A; Jacobson BA; Widom A; Cook TA; Xu X; Barry AB; Goldman SJ; Abraham WM
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):368-76. PubMed ID: 17023688
[TBL] [Abstract][Full Text] [Related]
5. Effects of an antibody to interleukin-5 in a monkey model of asthma.
Mauser PJ; Pitman AM; Fernandez X; Foran SK; Adams GK; Kreutner W; Egan RW; Chapman RW
Am J Respir Crit Care Med; 1995 Aug; 152(2):467-72. PubMed ID: 7633694
[TBL] [Abstract][Full Text] [Related]
6. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
[TBL] [Abstract][Full Text] [Related]
7. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
[TBL] [Abstract][Full Text] [Related]
9. Modulation of murine experimental asthma by Ascaris suum components.
Itami DM; Oshiro TM; Araujo CA; Perini A; Martins MA; Macedo MS; Macedo-Soares MF
Clin Exp Allergy; 2005 Jul; 35(7):873-9. PubMed ID: 16008672
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor 2 blockade prevents asthma in a cynomolgus monkey model.
Mellado M; Martín de Ana A; Gómez L; Martínez C; Rodríguez-Frade JM
J Pharmacol Exp Ther; 2008 Feb; 324(2):769-75. PubMed ID: 18029547
[TBL] [Abstract][Full Text] [Related]
11. Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.
Katoh S; Oomizu S; Niki T; Shimizu H; Obase Y; Korenaga M; Oka M; Hirashima M
Int Arch Allergy Immunol; 2012; 158 Suppl 1():58-65. PubMed ID: 22627368
[TBL] [Abstract][Full Text] [Related]
12. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma.
Tomkinson A; Tepper J; Morton M; Bowden A; Stevens L; Harris P; Lindell D; Fitch N; Gundel R; Getz EB
Allergy; 2010 Jan; 65(1):69-77. PubMed ID: 19796211
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice.
Yang G; Li L; Volk A; Emmell E; Petley T; Giles-Komar J; Rafferty P; Lakshminarayanan M; Griswold DE; Bugelski PJ; Das AM
J Pharmacol Exp Ther; 2005 Apr; 313(1):8-15. PubMed ID: 15644434
[TBL] [Abstract][Full Text] [Related]
14. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice.
Ma Y; HayGlass KT; Becker AB; Fan Y; Yang X; Basu S; Srinivasan G; Simons FE; Halayko AJ; Peng Z
Am J Respir Crit Care Med; 2007 Sep; 176(5):439-45. PubMed ID: 17556715
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with recombinant Ascaris suum 24-kilodalton antigen induces a Th1/Th2-mixed type immune response and confers high levels of protection against challenged Ascaris suum lung-stage infection in BALB/c mice.
Islam MK; Miyoshi T; Tsuji N
Int J Parasitol; 2005 Aug; 35(9):1023-30. PubMed ID: 15998515
[TBL] [Abstract][Full Text] [Related]
16. A latex-induced allergic airway inflammation model in mice.
Farzaneh P; Hassan ZM; Pourpak Z; Hoseini AZ; Hogan SP
Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):405-11. PubMed ID: 17169120
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.
Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T
Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862
[TBL] [Abstract][Full Text] [Related]
19. Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration.
Wells JW; Cowled CJ; Giorgini A; Kemeny DM; Noble A
J Allergy Clin Immunol; 2007 Jan; 119(1):226-34. PubMed ID: 17208606
[TBL] [Abstract][Full Text] [Related]
20. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.
Katoh S; Matsumoto N; Kawakita K; Tominaga A; Kincade PW; Matsukura S
J Clin Invest; 2003 May; 111(10):1563-70. PubMed ID: 12750406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
